Stefania Piconi

8PUBLICATIONS
34CO-AUTHORS
Pacific Peoples sport and physical activityGene and molecular therapyMedical infection agents (incl. prions)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2026
Rezafungin as Primary Prophylaxis of Pneumocystis jirovecii Pneumonia in a Critically Ill Person Presenting with AIDS with Trimethoprim/Sulfamethoxazole Allergy: A Case Report.

Martina Bottanelli, Alice Mulè, Chiara Molteni

|Jan 16, 2026
Acute hepatitis B following a switch to long-acting cabotegravir plus rilpivirine in an individual with a history of hepatitis B vaccination.

Valentina Morena, Nicole Gemignani, Martina Bottanelli

|Oct 22, 2025
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco).

Valentina Morena, Federico Conti, Dario Cattaneo

|Sep 28, 2024
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements.

Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi

|Jul 27, 2024
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort.

Marco Fois, Andrea De Vito, Francesca Cherchi

|Jul 12, 2024
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy).

Giacomo Ponta, Valentina Morena, Martina Strano

Pageof 2

Frequent Collaborators

2 joint publications

Giuseppe Vittorio De Socio

2 joint publications

Silvia Pontiggia

2 joint publications

Chiara Molteni

1 joint publications

Stefano Renzetti